Self-Study of Graduate Education
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Scientific Council Dinner PRESENTING the KLERMAN & FREEDMAN AWARDS
BRAIN & BEHAVIOR RESEARCH FOUNDATION Scientific Council Dinner PRESENTING THE KLERMAN & FREEDMAN AWARDS FRIDAY, JULY 27, 2018 METROPOLITAN CLUB NEW YORK 1 Welcome to the Scientific Council Dinner 24th ANNUAL KLERMAN PRIZE where we will present the 2018 Klerman FOR EXCEPTIONAL CLINICAL RESEARCH & Freedman Awards. Albert R. Powers III, M.D., Ph.D. The Scientific Council, led by its founding President, Dr. Herbert Pardes, review Yale University School of Medicine and select the most promising research ideas with the greatest potential to lead to further breakthroughs. We thank them for their time, expertise, and HONORABLE MENTION judgement to support the mission of the Foundation. Tonight we will recognize and honor the exceptional work of some of the out- Timothy Y. Mariano, M.D., Ph.D., MSc standing researchers who have received awards through the Brain & Behavior Harvard Medical School Research Foundation’s Young Investigator Grant program, which supports Brigham and Women’s Hospital young scientists as they gather pilot data and “proof of concept” for their Butler Hospital innovative clinical and basic research. The Prizes are named for Gerald L. Klerman and Daniel X. Freedman, two neuro- psychiatry pioneers who played seminal roles as researchers, teachers, physicians and administrators. Their outstanding contributions continue to inspire scientists st who knew them, as well as those who are just entering the field. The prizewinners 21 ANNUAL FREEDMAN PRIZE are selected by committees of the Foundation’s Scientific Council. FOR EXCEPTIONAL BASIC RESEARCH Five young researchers are being recognized tonight for their work in psychosis, non-invasive brain stimulation to treat chronic back pain which can often lead Byungkook Lim, Ph.D. -
The Creation of Neuroscience
The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits. -
GSK3 Signalling Regulates Mammalian Axon Regeneration by Inducing the Expression of Smad1
ARTICLE Received 28 Mar 2013 | Accepted 27 Sep 2013 | Published 28 Oct 2013 DOI: 10.1038/ncomms3690 PI3K–GSK3 signalling regulates mammalian axon regeneration by inducing the expression of Smad1 Saijilafu1,*, Eun-Mi Hur1,2,*, Chang-Mei Liu1, Zhongxian Jiao1, Wen-Lin Xu1 & Feng-Quan Zhou1,3 In contrast to neurons in the central nervous system, mature neurons in the mammalian peripheral nervous system (PNS) can regenerate axons after injury, in part, by enhancing intrinsic growth competence. However, the signalling pathways that enhance the growth potential and induce spontaneous axon regeneration remain poorly understood. Here we reveal that phosphatidylinositol 3-kinase (PI3K) signalling is activated in response to peripheral axotomy and that PI3K pathway is required for sensory axon regeneration. Moreover, we show that glycogen synthase kinase 3 (GSK3), rather than mammalian target of rapamycin, mediates PI3K-dependent augmentation of the growth potential in the PNS. Furthermore, we show that PI3K–GSK3 signal is conveyed by the induction of a transcription factor Smad1 and that acute depletion of Smad1 in adult mice prevents axon regeneration in vivo. Together, these results suggest PI3K–GSK3–Smad1 signalling as a central module for promoting sensory axon regeneration in the mammalian nervous system. 1 Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. 2 Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Seoul 136-791, Republic of Korea. 3 The Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. * These authors contributed equally to this work. -
2010 Program Meeting Schedule
Vision Sciences Society 10th Annual Meeting, May 7-12, 2010 Naples Grande Resort & Club, Naples, Florida Program Contents Board, Review Committee & Staff . 2 Satellite Events. 22 Keynote Address . 3 Club Vision Dance Party. 22 Meeting Schedule . 4 Open House . 23 Schedule-at-a-Glance . 6 Member-Initiated Symposia . 24 Poster Schedule . 8 Friday Sessions . 29 Talk Schedule . 10 Saturday Sessions . 33 Young Investigator Award . 11 Sunday Sessions . 43 Abstract Numbering System. 11 Monday Sessions . 53 VSS Dinner and Demo Night . 12 Tuesday Sessions . 58 VSS Public Lecture . 15 Wednesday Sessions . 68 VSS at ARVO . 15 Topic Index. 71 Attendee Resources . 16 Author Index . 74 Exhibitors . 19 Hotel Floorplan . 86 Travel Awards . 21 Advertisements. 89 Board, Review Committee & Staff Board of Directors Abstract Review Committee Tony Movshon (2011), President David Alais Laurence Maloney New York University Marty Banks Ennio Mingolla Pascal Mamassian (2012), President Elect Irving Biederman Cathleen Moore CNRS & Université Paris 5 Geoff Boynton Shin’ya Nishida Eli Brenner Tony Norcia Bill Geisler (2010), Past President Angela Brown Aude Oliva University of Texas, Austin David Burr Alice O’Toole Marisa Carrasco (2012), Treasurer Patrick Cavanagh John Reynolds New York University Marvin Chun Anna Roe Barbara Dosher (2013) Jody Culham Brian Rogers University of California, Irvine Greg DeAngelis Jeff Schall James Elder Brian Scholl Karl Gegenfurtner (2013) Steve Engel David Sheinberg Justus-Liebig Universität Giessen, Germany Jim Enns Daniel Simons -
Preliminary Program Dopamine 2016, Vienna, Austria Monday, September
Last Update: May. 2, 2016. Preliminary Program Dopamine 2016, Vienna, Austria Monday, September 5th 09:00 Registration 11:00 Opening Remarks, Welcome Addresses 11:15 Plenary Lecture 1: Chair: Antonello Bonci (NIDA-IRP, Baltimore, USA) Introduction 11:20 Karl Deisseroth (Stanford University, USA) Title to be announced 12:15 Short lunch break 13:00 Parallel Symposium 1: Thinking locally, acting globally: novel mechanisms for regulation of the response characteristics of dopamine neurons Chair: Susan G Amara (NIMH, USA) Co-Chair: Aurelio Galli (Vanderbilt Kennedy Center, Nashville, USA) Introduction 13:10 Speaker 1: Suzanne M Underhill, (NIMH, USA) Regulated trafficking of dopamine and glutamate transporters: a mechanism for signal integration by dopamine neurons 13:35 Speaker 2: Susan L. Ingram (Oregon Health & Science University, USA) Amphetamine increases dopamine neuron NMDA-GluN2B synaptic currents involved in locomotor stimulation 14:00 Speaker 3: Sweyta Lohani (University of Pittsburgh, USA) Modulation of prefrontal cortex and striatal networks by VTA dopamine neurons 14:25 Speaker 4: Andrew Yee (Physiology, Centre for Brain Res, University of Auckland, New Zealand) Activity-dependence of dopamine release from the somato-dendritic region of nigral dopaminergic neurons 13:00 Parallel Symposium 2: Functional diversity of dopamine signalling in the mammalian brain Chair: Stephan Lammel, (University of California, Berkeley, USA), Co-Chair: Robert Malenka (Stanford University, USA) Introduction 13:10 Speaker 1: Robert Malenka (Stanford -
Annual Report Fy 2018 Human Frontier Science Program Organization
APRIL 2017 APRIL 2018 — MARCH 2019 ANNUAL REPORT FY 2018 HUMAN FRONTIER SCIENCE PROGRAM ORGANIZATION The Human Frontier Science Program Organization (HFSPO) is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. Special emphasis is given to the support and training of independent young investigators, beginning at the postdoctoral level. The Program is implemented by an international organisation, supported financially by Australia, Canada, France, Germany, India, Italy, Japan, the Republic of Korea, New Zealand, Norway, Singapore, Switzerland, the United Kingdom of Great Britain and Nothern Ireland, the United States of America, and the European Commission. Since 1990, over 7000 researchers from more than 70 countries have been supported. Of these, 28 HFSP awardees have gone on to receive the Nobel Prize. 2 The following documents are available on the HFSP website www.hfsp.org: Joint Communiqués (Tokyo 1992, Washington 1997, Berlin 2002, Bern 2004, Ottawa 2007, Canberra 2010, Brussels 2013, London 2016): https://www.hfsp.org/about/governance/membership Statutes of the International Human Frontier Science Program Organization: https://www.hfsp.org/about/governance/hfspo-statutes Guidelines for the participation of new members in HFSPO: https://www.hfsp.org/about/governance/membership General reviews of the HFSP (1996, 2001, 2006-2007, 2010, 2018): https://www.hfsp.org/about/strategy/reviews Updated and previous lists of awards, including titles and abstracts: -
View Final Program
142nd ANNUAL MEETING OF THE AMERICAN ANA2017 NEUROLOGICAL ASSOCIATION SAN DIEGO, CA • OCTOBER 15-17, 2017 SHERATON SAN DIEGO HOTEL & MARINA EXPLORE • EXAMINE • INVESTIGATE FINAL PROGRAM OCTOBER 14, 2017 | Pre-Meeting Symposium: Big Science and the BRAIN Initiative 2017.MYANA.org 142nd ANNUAL MEETING OF THE AMERICAN ANA2017 NEUROLOGICAL ASSOCIATION SAN DIEGO, CA • OCTOBER 15 -17, 2017 SHERATON SAN DIEGO HOTEL & MARINA ND Please note some session titles may have changed since this program was printed. Please refer THE 142 ANA to your Mobile app for the most current session updates. ANNUAL MEETING LETTER FROM THE CHAIR 3 Enjoy outstanding scientific SCHEDULE AT A GLANCE 4 symposia covering the latest HOTEL FLOOR PLANS 6 research in the fields of neurology and neuroscience GENERAL INFORMATION 7 while taking the opportunity WIRELESS CONNECTION 8 to network with leaders in the world of academic neurology CONTINUING MEDICAL EDUCATION 8 at the 142nd ANA Annual ANNUAL MEETING MOBILE APP 8 Meeting in San Diego, CA, October 15-17, 2017. PROGRAMS BY DAY 9 SATURDAY OCT 14 9 MEETING LOCATION SUNDAY OCT 15 9 Sheraton San Diego MONDAY OCT 16 17 Hotel & Marina 1380 Harbor Island Drive TUESDAY OCT 17 25 San Diego, California 92101 IN MEMORIAM 28 ONSITE MEETING CONTACTS SPEAKER ABSTRACTS 29 Registration and meeting questions: THANK YOU TO OUR SUPPORTERS & EXHIBITORS 42 [email protected] FUTURE MEETING DATES 42 OR visit the registration desk Bay View Foyer 2017 AWARDEES 43 (located in Marina Tower Lobby Level) ACADEMIC NEUROLOGY REPRESENTATIVES FROM JAPAN 47 Saturday, October 14 2017 ABSTRACT REVIEWERS 48 3:00 PM–7:00 PM BOARD OF DIRECTORS 49 Sunday, October 15 6:00 AM–5:45 PM ANA 2017 COMMITTEES, SUBCOMMITTEES & TASK FORCES 50 Monday, October 16 6:30 AM–5:45 PM Tuesday, October 17 6:30 AM–2:15 PM #ANAMTG2017 ANA 2017 FROM THE CHAIR Dear Colleagues, It is a pleasure to welcome you to the 142nd Annual Meeting of the American Neurological Association (ANA). -
Pioneering Solutions for Depression and Bipolar Disorder the Stanford Mood Disorders Center
Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center Campaign for Stanford Medicine We are all part of the equation. “Never before have we been so close to breakthroughs that will transform our approach to mood disorders, delivering advanced solutions for sufferers, their families, their friends, and their communities. Stanford is leading the way in understanding brain processes and transforming new knowledge, rapidly and efficiently, into new therapies and technologies.” Alan F. Schatzberg, MD THE KENNETH T. NORRIS, JR. PROFESSOR AND CHAIR EMERITUS, STANFORD DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center One out of five Americans will experience some form of mood disorder in their lifetime—such as depression or bi- polar disorder. Despite their prevalence, mood disorders remain one of the most widespread, misunderstood, and stigmatized health issues we face. Their impact reverber- ates far beyond an individual’s life. Families, friends, com- munities, economies—all are affected by these diseases. By 2020, depression will rank second in morbidity among all illnesses worldwide; bipolar disorder will rank fifth. Tragically, suicide, often triggered by a mood disorder, takes more than one million lives worldwide every year. Although the incidence and impact of mood disorders are undeniably on the rise, hope for solutions has never been higher. Through the Stanford Mood Disorders Center and Research Program, scientists and physicians are building on Stanford’s traditions of excellence, healing, and innovation. They are leveraging new knowledge of genetics and the brain’s molecular processes, and drawing on new techniques for imaging and healing the brain. -
Consciousness, Accessibility, and the Mesh Between Psychology and Neuroscience
BEHAVIORAL AND BRAIN SCIENCES (2007) 30, 481–548 Printed in the United States of America doi: 10.1017/S0140525X07002786 Consciousness, accessibility, and the mesh between psychology and neuroscience Ned Block Department of Philosophy, New York University, New York, NY 10003 [email protected] Abstract: How can we disentangle the neural basis of phenomenal consciousness from the neural machinery of the cognitive access that underlies reports of phenomenal consciousness? We see the problem in stark form if we ask how we can tell whether representations inside a Fodorian module are phenomenally conscious. The methodology would seem straightforward: Find the neural natural kinds that are the basis of phenomenal consciousness in clear cases – when subjects are completely confident and we have no reason to doubt their authority – and look to see whether those neural natural kinds exist within Fodorian modules. But a puzzle arises: Do we include the machinery underlying reportability within the neural natural kinds of the clear cases? If the answer is “Yes,” then there can be no phenomenally conscious representations in Fodorian modules. But how can we know if the answer is “Yes”? The suggested methodology requires an answer to the question it was supposed to answer! This target article argues for an abstract solution to the problem and exhibits a source of empirical data that is relevant, data that show that in a certain sense phenomenal consciousness overflows cognitive accessibility. I argue that we can find a neural realizer of this overflow if we assume that the neural basis of phenomenal consciousness does not include the neural basis of cognitive accessibility and that this assumption is justified (other things being equal) by the explanations it allows. -
List of Entries
List of Entries Essays are shown in bold A Afferent Fibers (Neurons) Acid-Sensing Ion Channels AFibers(A-Fibers) NICOLAS VOILLEY,MICHEL LAZDUNSKI A Beta(β) Afferent Fibers Acinar Cell Injury A Delta(δ) Afferent Fibers (Axons) Acrylamide A Delta(δ)-Mechanoheat Receptor Acting-Out A Delta(δ)-Mechanoreceptor Action AAV Action Potential Abacterial Meningitis Action Potential Conduction of C-Fibres Abdominal Skin Reflex Action Potential in Different Nociceptor Populations Abduction Actiq® Aberrant Drug-Related Behaviors ® Ablation Activa Abnormal Illness Affirming States Activation Threshold Abnormal Illness Behavior Activation/Reassurance GEOFFREY HARDING Abnormal Illness Behaviour of the Unconsciously Motivated, Somatically Focussed Type Active Abnormal Temporal Summation Active Inhibition Abnormal Ureteric Peristalsis in Stone Rats Active Locus Abscess Active Myofascial Trigger Point Absolute Detection Threshold Activities of Daily Living Absorption Activity ACC Activity Limitations Accelerated Recovery Programs Activity Measurement Acceleration-Deceleration Injury Activity Mobilization Accelerometer Activity-Dependent Plasticity Accommodation (of a Nerve Fiber) Acupuncture Acculturation Acupuncture Efficacy EDZARD ERNST Accuracy and Reliability of Memory Acupuncture Mechanisms β ACE-Inhibitors, Beta( )-Blockers CHRISTER P.O. C ARLSSON Acetaminophen Acupuncture-Like TENS Acetylation Acute Backache Acetylcholine Acute Experimental Monoarthritis Acetylcholine Receptors Acute Experimental -
At Storrs Th 5:00 Pm5:00 Universityconnecticutof Annual – Laurelhall,Floor First – 8:30 Pm 8:30 Th , 2016 , ITINERARY 5 Pm – 6 Pm …… Keynote Lecture
An event organized by the HERE PLACE PLACE UCONN Interdisciplinary STAMP Neuroscience Program Steering Committee with the support of the 20th Annual UCONN OVPR Scholarship Facilitation Fund Neuroscience and the contribution of the at Storrs departments of Biomedical Engineering Electrical & Computer Eng. Monday, October 24th, 2016 Pharmaceutical Sciences Physiology & Neurobiology Psychological Sciences and the CT Institute for the Brain For more info visit 5:00 pm – 8:30 pm and Cognitive Sciences http://neuroscience.uconn.edu/ University of Connecticut Storrs Campus – Laurel Hall, First Floor ITINERARY 5 pm – 6 pm …… Keynote Lecture David Ginty, Ph.D. Professor, Harvard Medical School, Boston MA 6 pm – 8:30 pm ......Poster Session & Reception During the poster session, Ph.D. students, postdoctoral fellows, and researchers from across campus will present their work in Keynote Lecture Keynote Speaker poster format. Everybody is welcome to interact informally over food and drinks. A Molecular-genetic David Ginty, Ph.D. Professor, Harvard Medical 7 pm – 8 pm ……………. Data Blitz Approach to Decoding School Investigator, Howard Hughes The Data Blitz is a fun way for trainees to the Sense of Touch Medical Institute present their research in a concise manner http://gintylab.hms.harvard.edu/ to a diverse audience by encapsulating Abstract: The somatosensory system endows us Bio: Dr. Ginty received a degree in biology from Mount their work in a 3 minute-long presentation with a remarkable capacity for object recognition, Saint Mary’s College (1984) and a Ph.D. in physiology and limited to only 3 PowerPoint slides. The texture discrimination, sensory-motor feedback, from East Carolina University School of Medicine bell will be rung at the end of the 3 and social exchange. -
FY2006 Society for Neuroscience Annual Report
Navigating A Changing Landscape FY2006 Annual Report 2005–2006 Society for 2005–2006 Society Past Presidents Neuroscience Council for Neuroscience Committee Chairs Carol A. Barnes, PhD, 2004–05 OFFICERS Anne B. Young, MD, PhD, 2003–04 Stephen F. Heinemann, PhD Darwin K. Berg, PhD Huda Akil, PhD, 2002–03 President Audit Committee Fred H. Gage, PhD, 2001–02 David Van Essen, PhD John H. Morrison, PhD Donald L. Price, MD, 2000–01 President-Elect Committee on Animals in Research Dennis W. Choi, MD, PhD, 1999–00 Carol A. Barnes, PhD Irwin B. Levitan, PhD Edward G. Jones, MD, DPhil, 1998–99 Past President Committee on Committees Lorne M. Mendell, PhD, 1997–98 Bruce S. McEwen, PhD, 1996–97 Michael E. Goldberg, MD William J. Martin, PhD Treasurer Committee on Diversity in Neuroscience Pasko Rakic, MD, PhD, 1995–96 Carla J. Shatz, PhD, 1994–95 Christine M. Gall, PhD Rita J. Balice-Gordon, PhD Larry R. Squire, PhD, 1993–94 Treasurer-Elect Judy Illes, PhD (Co-chairs) Committee on Women in Neuroscience Ira B. Black, MD, 1992–93 William T. Greenough, PhD Joseph T. Coyle, MD, 1991–92 Past Treasurer Michael E. Goldberg, MD Robert H. Wurtz, PhD, 1990–91 Finance Committee Irwin B. Levitan, PhD Patricia S. Goldman-Rakic, PhD, 1989–90 Secretary Mahlon R. DeLong, MD David H. Hubel, MD, 1988–89 Government and Public Affairs Committee Albert J. Aguayo, MD, 1987–88 COUNCILORS Darwin K. Berg, PhD Laurence Abbott, PhD Mortimer Mishkin, PhD, 1986–87 Information Technology Committee Bernice Grafstein, PhD, 1985–86 Joanne E. Berger-Sweeney, PhD William D.